Hyperbaric oxygen therapy associated with improved sleep quality in retrospective cohort study
A retrospective longitudinal cohort study evaluated the effect of hyperbaric oxygen therapy (HBOT) on sleep quality in 395 patients at the Sagol Center. Participants included 180 healthy aging patients, 92 long COVID patients, and 123 PTSD patients. All received 60 HBOT sessions (2.0 ATA, 100% oxygen, 90 minutes, 5 days/week). No comparator group was reported.
The primary outcome was change in Pittsburgh Sleep Quality Index (PSQI) total score. Results showed PSQI total scores improved significantly in all three patient groups (p<0.001). Secondary outcomes included PSQI component scores, but specific effect sizes and absolute numerical changes were not reported. Safety data, including adverse events, serious adverse events, discontinuations, and tolerability, were not reported.
Key limitations include the retrospective design and absence of a control group, which prevents establishing causality. Funding sources and conflicts of interest were not reported. The study's practice relevance is limited by its observational nature and lack of control data. These findings indicate an association between HBOT and improved sleep quality that should be interpreted cautiously pending randomized controlled trials.